BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30104240)

  • 1. Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated Cytotoxicity.
    Al Absi A; Wurzer H; Guerin C; Hoffmann C; Moreau F; Mao X; Brown-Clay J; Petrolli R; Casellas CP; Dieterle M; Thiery JP; Chouaib S; Berchem G; Janji B; Thomas C
    Cancer Res; 2018 Oct; 78(19):5631-5643. PubMed ID: 30104240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome
    Wurzer H; Filali L; Hoffmann C; Krecke M; Biolato AM; Mastio J; De Wilde S; François JH; Largeot A; Berchem G; Paggetti J; Moussay E; Thomas C
    Front Immunol; 2021; 12():619069. PubMed ID: 34108958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.
    Baginska J; Viry E; Berchem G; Poli A; Noman MZ; van Moer K; Medves S; Zimmer J; Oudin A; Niclou SP; Bleackley RC; Goping IS; Chouaib S; Janji B
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17450-5. PubMed ID: 24101526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKG2D-DAP10 signaling recruits EVL to the cytotoxic synapse to generate F-actin and promote NK cell cytotoxicity.
    Wilton KM; Overlee BL; Billadeau DD
    J Cell Sci; 2019 Jul; 133(5):. PubMed ID: 31235500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.
    Cifaldi L; Prencipe G; Caiello I; Bracaglia C; Locatelli F; De Benedetti F; Strippoli R
    Arthritis Rheumatol; 2015 Nov; 67(11):3037-46. PubMed ID: 26251193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement.
    Huang W; Ochs HD; Dupont B; Vyas YM
    J Immunol; 2005 Mar; 174(5):2602-11. PubMed ID: 15728466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect.
    Gismondi A; Cifaldi L; Mazza C; Giliani S; Parolini S; Morrone S; Jacobelli J; Bandiera E; Notarangelo L; Santoni A
    Blood; 2004 Jul; 104(2):436-43. PubMed ID: 15001467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.
    Scott GB; Bowles PA; Wilson EB; Meade JL; Low BC; Davison A; Blair GE; Cook GP
    Biochem J; 2010 Nov; 431(3):423-31. PubMed ID: 20704564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
    Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
    Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance against natural killer cell cytotoxicity: analysis of mechanisms.
    Hasenkamp J; Borgerding A; Wulf G; Uhrberg M; Jung W; Dingeldein S; Truemper L; Glass B
    Scand J Immunol; 2006 Oct; 64(4):444-9. PubMed ID: 16970688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse.
    Taouk G; Hussein O; Zekak M; Abouelghar A; Al-Sarraj Y; Abdelalim EM; Karam M
    Sci Rep; 2019 Jun; 9(1):8756. PubMed ID: 31217484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity.
    Hazeldine J; Hampson P; Lord JM
    Aging Cell; 2012 Oct; 11(5):751-9. PubMed ID: 22642232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdc42-interacting protein-4 functionally links actin and microtubule networks at the cytolytic NK cell immunological synapse.
    Banerjee PP; Pandey R; Zheng R; Suhoski MM; Monaco-Shawver L; Orange JS
    J Exp Med; 2007 Oct; 204(10):2305-20. PubMed ID: 17785506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evasion of NK cell immune surveillance
    Peng JM; Chiu CF; Cheng JH; Liu HY; Chang YL; Luo JW; Weng YT; Luo HL
    Front Immunol; 2022; 13():883178. PubMed ID: 36032170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD56
    Jaime P; García-Guerrero N; Estella R; Pardo J; García-Álvarez F; Martinez-Lostao L
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1708-1718. PubMed ID: 28668542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells.
    Breunig C; Pahl J; Küblbeck M; Miller M; Antonelli D; Erdem N; Wirth C; Will R; Bott A; Cerwenka A; Wiemann S
    Cell Death Dis; 2017 Aug; 8(8):e2973. PubMed ID: 28771222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagic degradation of GZMB/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis.
    Viry E; Baginska J; Berchem G; Noman MZ; Medves S; Chouaib S; Janji B
    Autophagy; 2014 Jan; 10(1):173-5. PubMed ID: 24248158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer.
    Slattery K; Woods E; Zaiatz-Bittencourt V; Marks S; Chew S; Conroy M; Goggin C; MacEochagain C; Kennedy J; Lucas S; Finlay DK; Gardiner CM
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33568351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WIP is essential for lytic granule polarization and NK cell cytotoxicity.
    Krzewski K; Chen X; Strominger JL
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2568-73. PubMed ID: 18258743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.